
GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports
GE HealthCare Technologies is reportedly engaged in late-stage negotiations to acquire radiopharmaceutical developer Sofie Biosciences for approximately $1 billion. According to individuals familiar with the matter cited by financial media reports, a formal agreement could be announced as early as next week. Neither company has officially confirmed the discussions, and...








